Click for AI-narrated audio
Why Some Firms Default to Viewing Healthcare Marketing as Overhead
Some firms are trained to find and eliminate inefficiency. When they look at a marketing budget without a clear financial model connecting spend to returns, their instinct is rational: cut it. The problem is not that your operating partners are wrong to ask the question. The problem is that most multi-site healthcare marketing functions have not built the infrastructure to answer it compellingly. Whether you are running a behavioral health platform, an ophthalmology network, an urgent care platform, a dental or DSO platform, a dermatology group, a veterinary company, an OB/GYN practice management company, an orthopedic group, an autism treatment center, a fertility clinic, a physical therapy company or a plastic surgery platform, the dynamic is the same. Until marketing can show its contribution in EBITDA terms, it will always be vulnerable to the next budget cycle.
The Three Metrics Your Operating Partners Actually Care About
Forget impressions, clicks, and engagement rates. The metrics that move conversations are same-site revenue growth, de novo ramp speed, and cost of patient acquisition relative to contribution margin. These are the financial levers your sponsors track in every board meeting. Healthcare marketing that cannot demonstrate its contribution to these three areas is, from a business perspective, discretionary spend. Marketing that can demonstrate that contribution becomes a capital allocation priority.
Translating Healthcare Marketing Spend Into EBITDA Language
The shift from marketing language to financial language is simpler than most CMOs think, but it requires building a different reporting infrastructure. Instead of reporting on campaign performance, you report on revenue outcomes. Instead of measuring cost per lead, you measure cost per profitable patient. Instead of presenting impressions, you present same-site revenue contribution by location. When you make this shift, the budget conversation changes fundamentally — because you are no longer asking for money to run campaigns. You are asking for capital to generate returns.
Building the Internal Case: Same-Site, De Novo, and CAC as Portfolio Levers
The most effective budget defense frames marketing as three distinct financial levers operating simultaneously. Same-site revenue campaigns increase production density in mature locations without adding overhead. De novo launch programs compress the ramp curve, reducing the IRR drag of new locations reaching maturity. And CAC management at portfolio scale redirects media spend from low-performing channels to high-performing ones, improving margin without increasing the total budget. Presented together, these three levers tell a financial story that operating partners understand and respect — whether your platform delivers therapy visits, eye exams, urgent care encounters, dental visits, skin procedures, veterinary services, OB/GYN care, orthopedic consultations, autism assessments, fertility treatments, physical therapy sessions or plastic surgery procedures.
What Board-Ready Healthcare Marketing Reporting Looks Like
Most agencies give CMOs and Marketing VPs marketing reports. Board-ready reporting looks different. It shows marketing’s contribution to same-site EBITDA by location cluster, the blended cost per acquired patient across channels and markets, new location ramp performance versus the investment thesis model, and the trajectory of these metrics over time. When you walk into a board meeting with this data instead of a campaign recap, the conversation about marketing’s value is already won before you speak.
A Framework for Your Next Budget Conversation
Before your next budget meeting, build three exhibits: a one-page summary showing same-site revenue contribution by marketing channel over the last 12 months, a de novo ramp comparison showing locations with full pre-opening marketing investment versus those without, and a CAC trend analysis showing improvement over time. These three exhibits, presented in EBITDA terms, reframe the entire conversation — from cost center to growth investment. That is the framing your operating partners will respond to.
“The CMOs who win budget conversations are the ones who show up with financial data, not marketing metrics.”
If your current healthcare marketing agency cannot help you make this case to your operating partners, you may not have the right agency. Download our one-pager on the Agency Creative approach to multi-site healthcare marketing.
Learn how Agency Creative can help boost your brand by calling us at 972.488.1660 or by contacting us online.
See More Work
